SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$20.67
-1.90% today
Updated 2026-04-29
Market cap
$2.18B
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$10 – $65
Volume
2.9M
Sarepta Therapeutics Inc (SRPT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-32.50%
Operating margin
-92.60%
ROE
-53.50%
ROA
-11.20%
Debt/equity
0.95x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $115291.00 | $-31.07M | 100.00% | -28,608.52% | -26,951.81% |
| 2007 | $10.99M | $-27.17M | 100.00% | -301.38% | -247.31% |
| 2008 | $21.26M | $-23.95M | 100.00% | -129.16% | -112.67% |
| 2009 | $17.59M | $-25.16M | 100.00% | -88.18% | -143.07% |
| 2010 | $29.42M | $-32.18M | 6.67% | -71.16% | -109.37% |
| 2011 | $46.99M | $-2.32M | 23.54% | -76.46% | -4.93% |
| 2012 | $37.33M | $-121.29M | -39.12% | -79.57% | -324.91% |
| 2013 | $14.22M | $-111.98M | -534.95% | -634.95% | -787.57% |
| 2014 | $9.76M | $-135.79M | -864.47% | -1,371.21% | -1,391.71% |
| 2015 | $1.25M | $-220.03M | 100.00% | -17,572.55% | -17,560.26% |
| 2016 | $5.42M | $-267.26M | 97.60% | -4,920.31% | -4,930.18% |
| 2017 | $154.58M | $-50.69M | 95.24% | -111.03% | -32.79% |
| 2018 | $301.03M | $-361.92M | 88.64% | -114.15% | -120.22% |
| 2019 | $380.83M | $-715.08M | 85.14% | -185.27% | -187.77% |
| 2020 | $540.10M | $-554.13M | 88.26% | -104.46% | -102.60% |
| 2021 | $701.89M | $-418.78M | 86.17% | -65.50% | -59.66% |
| 2022 | $933.01M | $-703.49M | 85.00% | -57.47% | -75.40% |
| 2023 | $1.24B | $-535.98M | 87.91% | -21.54% | -43.11% |
| 2024 | $1.90B | $235.24M | 83.22% | 11.47% | 12.37% |
| 2025 | $2.20B | $-713.41M | 59.90% | -29.92% | -32.45% |